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 Guinea pig (GP) sera seropositive to human parainfluenza 
virus type 3 (PIV-3) antigen were found previously in our 
laboratory. In the present study, we attempted to isolate 
and characterize a new agent from GP colonies. The new 
agent was isolated from lung homogenate of sentinel GPs, 
which were maintained in the GP room containing the 
serologically positive GP breeding colony. This new agent 
was found to be comparable to human and bovine PIV-3 
strains in regard to its moderate cytopathic effects, 
hemagglutinating activity, and neutralizing activity, and 
moreover, it was found to produce antigens cross-reactive 
to both of the latter PIV-3s. The resemblance between the 
new isolates and the other PIV-3s was supported by the 
SDS-PAGE and Western blot analysis of the viral proteins. 
This is the first report of the isolation of a type 3-like 
parainfluenza virus from GP. This finding is significant, in-
sofar as an inapparent infection with the virus may con-
cern animal experimentation in the use of GP. 
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Introduction
there have as yet been no published reports of the iso-
lation of PIV-3 from GP. GPs seropositive to both 
human and bovine PIV-3s antigens were recently 
found in our laboratory. In the present study, we 
therefore attempted to isolate and characterize a new 
PIV-3 strain from these seropositive GP.
Materials and Methods
Sentinel animals 
 Sentinel animals (4-week-old germ-free GP of the 
Hartley strain) supplied by Nihon SLC (Hamamatsu, 
Shizuoka, Japan) were maintained in the breeding 
room containing GP that were serologically reactive to 
human and bovine PIV-3 antigens. At 8, 10, 12, and 
14 days of exposure, one of the four each animal was 
placed under general anesthesia with diethyl ether or. 
pentobarbital for bleeding and euthanasia. The blood 
and lung specimens were collected for serological tests 
and virus isolation. These procedures were conducted 
under the Guidelines for the Animal Care and Use 
Committee of Nagasaki University.
 Parainfluenza viruses (PIVs) belong to the family 
Paramyxoviridae and are important respiratory tract 
pathogens in human and non-human animals. The 
PIVs include at least four different serological types 
(PIV types 1-4). PIV types 1, 2, and 3 are a major 
cause of croup and bronchiolitis in infants and child-
ren' 3 >. Animal strains of PIVs have been reported in 
mice (murine PIV-1; Sendai virus) 4 ' 11, cattle (bovine 
PIV-3) 6 ), and dogs'), but not in guinea pigs (GP). 
Serological evidence has been reported and which sug-
gested the infection of GP with PIV-3'''). However,
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Viruses and culture cells 
 The 65-899 strain of human PIV-3 (provided by 
courtesy of Dr. Y. Ito, Mie University School of 
Medicine), the C243 strain of human PIV-3 (purchased 
from American Type Culture Collection, Rockville, 
MD, USA), the 910N and YN strains of bovine PIV-3 
(donated by Dr. Y. Iwakura, Institute of Medical 
Science, University of Tokyo), simian virus type 5 
(SV-5), and murine PIV-1 (both provided by the late of 
Dr. M. Nakagawa and Dr. M. Arita, National Institute 
of Health, Japan) were used as control PIVs. The 
growth and maintenance of culture cells and the 
method of serological tests were in accordance with 
the previous description". In short, the B95a, BHK-
21/clone 13, BSC-1, MA-104, MDBK, and Vero cell 
lines were maintained in Eagle's minimum essential 
medium (MEM; Gibco Co., Grand Island, NY, USA)
containing 10% or 5% heat-inactivated fetal calf serum 
(FCS; Hyclone Lab., Logan, UT, USA) and antibiotics. 
For the production of stock virus and hemagglutinin 
(HA), the cells were inoculated with each of the six 
viruses at a multiplicity of infection of about 1. The 
supernatants were employed in hemagglutination-
inhibition (HI) and viral neutralization (VN) tests as 
virus antigen.
Virus isolation 
 The removed GP lungs were suspended with MEM 
with 5% FCS (5MEM) and prepared as a 10% (w/v) 
final concentration in an ice-bath using a glass 
homogenizer at 4,000 rpm for 1 min inside a biologi-
cal safety cabinet (Class II). Aliquots of the homogen-
ates were centrifuged at 2,000 rpm at 4 °C for 10 min, 
and two-fold dilutions of the supernatants were inocu-
lated into six different subconfluent cells. After the 
adsorption with supernatants, the inoculated cells 
were rinsed with 5MEM and cultured in a CO 2 incu-
bator at 37 °C . These cells were observed daily for 
cytopathic effects (CPE), and examined for an appear-
ance of viral antigen by indirect immunofluorescent 
antibody (IFA) test.
Characterization of isolates 
 A plaquing method was employed for measuring the 
PIVs' infectivity. The new isolates were examined in 
detail to determine their type of viral nucleic acid, 
sensitivity to ether treatment, HA production, 
hemadsorption (HAD) activity, and serological cross-
reactions using VN and HI tests. The viral nucleic 
acid was identified via treatments with an acridine or-
ange 7 and 5-iodo-2'-deoxyuridine (Wako Chemicals 
Co., Osaka)"'. The ether sensitivity and HI tests were 
performed according to the procedures described 
previously 121 For the detection of HA activity, a 0.5% 
erythrocyte suspension was used. The PIV-inoculated 
cells were also examined with HAD test to detect the 
HA antigen on the surface membrane of the cells 
tested. 
 Sodium dodecyl sulfate-polyacrylamide slab gel elec-
trophoresis (SDS-PAGE) and Western Blotting: The pu-
rified antigens were mixed with an equal volume of 
2x SDS sample buffer (0.1 M Tris-HC1 pH 6.8, 20% 
glycerol, 4% SDS, 2% 2-mercaptoethanol, and 0.001% 
bromophenol blue) heated at 100 °C for 2 min, and the 
aliquots were loaded onto a 10% acrylamide gel and 
electrophoresed at 120 volts for 4 h. Proteins on the 
separated gel were either stained with Coomassie blue 
or transferred to a nitrocellulose membrane (Millipore,
Bedford, MA, USA) at 6 volts overnight using a 
Semidryblotter (Sartorius, Gottingen, Germany). The 
protein bands were visualized by anti-new isolates 
antisera of rabbits and 4-chloro-l-naphthol substrate 
obtained from a commercial kit (Vector, Burlingame, 
CA, USA).
Results
 Four GPs confirmed to be seropositive to human 
PIV-3 were selected for the isolation of a new agent. 
Three-fourths of this sentinel GP group had shown 
seroconversion (1:16 in HI titer) 14 days after intro-
duction into the contaminated colony. At autopsy, no 
apparent disorders or consolidations were observed in 
any of the GP lungs. Lung homogenates of the four 
GPs were inoculated into B95a, BHK-21/clone 13, BSC-
1, MA-104, MDBK, and Vero cells, and the cells were 
observed daily and examined for the viral antigen 
using the IFA test. The new isolates induced moderate 
CPE with cell fusions in B95a cells, and rounding cell 
formation in MDBK and BHK-21/clone 13 cells on and 
after 2 days of incubation (Fig. 1). Moreover, IFA anti-
gens were observed in all cells after 1 day post-
inoculation (dpi). Three viral isolates were finally ob-
tained from the GP lungs taken on the 8th, 10th, and 
12th day of the group housing. The viral nucleic acid 
of new isolates was demonstrated to be single-
Fig. 1. Cell fusion (arrows) induced by the isolate in B95a 
cells (a), and rounding cell formations (arrowheads) in MDBK 
cells (b) at 2 days post-inoculation (dpi). a, b: x 150.
stranded RNA, as determined by acridine orange 
staining and by treatment with 5-iodo-2'-deoxyuridine. 
A marked reduction in infectivity was observed after 
treatment with diethyl ether for 18 h at 4 °C, indicat-
ing the ether-sensitive nature of the virus isolates. 
The virus isolates were also examined for HA produc-
tion with the erythrocytes of four mammalian species 
(mice, rats, GPs, and rabbits). Like human strain (65-
899) and bovine PIV-3 (strains 910N and YN), the iso-
lates agglutinated all of the erythrocytes. No differ-
ence in the HA titers and optimal temperatures for 
HA production were noticed with the erythrocytes 
from these animals. In HAD test using B95a and
MDBK cells, the fusions surrounded with the many 
rounded cells adsorbed many GP erythrocytes (Fig. 2). 
 Serologically, the new isolates were distinguished in 
HI and VN tests from murine PIV-1 and SV-5, insofar 
as the hemagglutination inhibition and neutralization 
activities were observed in only three strains of PIV-3 
(data not shown). The resemblance between the iso-
lates and other PIV-3s was supported by the SDS-
PAGE analysis of the viral proteins (Fig. 3). In the 
Western blot analysis, the anti-new isolate rabbit an-
tiserum showed many reactive bands in three strains 
of PIV-3 (Fig. 4), i.e., putative proteins of phosphoprotein 
(P), hemagglutinating glycoprotein (HN), fusion protein 
(F), nucleocapsid protein (NP), and others. Anti-new 
isolate matrix protein (M) antibody was not reactive 
with bovine PIV-3.
Fig. 2. In the hemadsorption test by MDBK cell on 2 dpi, the 
fusions surrounded with the many rounded cells adsorbed 
many GP erythrocytes (small round cells). x 150.
Fig. 4. Western blot analysis of the isolate, human PIV-3, bo-
vine PIV-3, murine PIV-1, and simian virus 5 (SV-5). Anti 
new isolate rabbit antiserum produced many reactive bands 
in the GP, human, and bovine PIV-3, but not in the murine 
PIV-1 or SV-5. Abbreviations at the left side show putative 
proteins; P: phosphoprotein; HN: hemagglutinating glycoprotein; 
FO: uncleaved fusion protein; Fl: large-subunit polypeptide of 
the cleaved fusion protein; NP: nucleocapsid protein; and M: 
matrix protein.
Discussion
Fig. 3. SDS-PAGE analysis of the isolate, human PIV-3, bo-
vine PIV-3, murine PIV-1, and SV-5. GP: new isolate; H3: 
human PIV-3; B3: bovine PIV-3; Ml: murine PIV-1; SV: sim-
ian virus 5; and MM: molecular size marker.
 No reports of PIV-3 isolated from GP have to date 
been published, even though serological evidence sug-
gesting the infection of GP with PIV-3 has emerged"). 
While the Sendai virus and SV-5 are animal strains of 
PIV-1 and PIV-2, respectively, there is no specific ani-
mal strain of PIV-3 in GPs. In this study, sentinels 
were introduced as roommates (not cagemates) to the
breeding room of GP, resulting in the isolation of a 
new agent which shared biological and physicochemi-
cal characteristics with both human and bovine PIV-
3s (especially human PIV-3). To our knowledge, this is 
the first report of a PIV-3-like agent isolated from a 
GP colony. 
 Although the GP sentinels in this study displayed 
no clinical signs after they were reared in the con-
taminated breeding room, histological and biochemical 
findings suggesting inflammatory responses in airway, 
i.e., interstitial pneumonia 13), an increased number of 
inflammatory cells in pulmonary lavage fluid"', an in-
crease in the histamine release from basophils15', and 
airway hyper reactivity to histamine` 16) have been 
observed in PIV-3 infected GP. PIVs are usually trans-
mitted by aerosol droplets or by direct or indirect 
contact with respiratory secretions, like other respira-
tory viruses. 
 In this report, it seemed that sentinel GPs were hori-
zontally infected via PIV-3 aerosol droplets. This 
raises the possibility that an inapparent infection with 
the new isolates may concern animal experimentation 
in the use of GP''. Further experimental examination 
is needed to clarify the effect of the virus infection in 
GP.
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